Same Indication

Ipilimumab vs Nitroglycerin

Ipilimumab vs Nitroglycerin: Overview

This comparison examines the pharmacological differences between Ipilimumab and Nitroglycerin.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Nitroglycerin: Nitric oxide donor causing venous and arterial vasodilation.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Nitroglycerin — 1-4 minutes.

Chemical Properties

Molecular Formula: Nitroglycerin — C3H5N3O9.

Molecular Weight: Nitroglycerin — 227.0870 g/mol.

Type: Ipilimumab — Antibody; Nitroglycerin — Small molecule.